INSTITUT ALLERGOSAN Trademark
Trademark Overview
On Wednesday, November 22, 2023, a trademark application was filed for INSTITUT ALLERGOSAN with the United States Patent and Trademark Office. The USPTO has given the INSTITUT ALLERGOSAN trademark a serial number of 79394824. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, December 5, 2024. This trademark is owned by Institut Allergosan pharmazeutische Produkte. The INSTITUT ALLERGOSAN trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Corporate management consultancy; providing office functions; advertising; public relations services; retail store services and online retail store services featuring cosmetics, skin care preparations, nutritional supplements, food supplements for dietetic use, food for medical or dietetic purposes, bacterial preparations for medical purposes, dietary supplements consisting primarily of vitamins and minerals for medical purposes and for dietetic purposes.
Provision of research services in the fields of probiotic bacteria, microbiome research, healthcare preparations, plant extracts and minerals; scientific consultancy services and research in relation to probiotic bacteria, plant extracts and minerals; research and development in the field of healthcare preparations; microbiome research; scientific research; professional scientific advisory services on drawing up scientific studies; professional scientific advisory services on the subject of scientific reports and postings; technical writing, namely preparation of scientific reports and preparation of scientific contributions in the fields of probiotic bacteria, microbiome research, healthcare preparations, plant extracts and minerals; conducting scientific analyses in the fields of probiotic bacteria, microbiome research, healthcare preparations, plant extracts and minerals; provision of scientific information and provision of counselling services in the field of clinical research.
General Information
Serial Number | 79394824 |
Word Mark | INSTITUT ALLERGOSAN |
Filing Date | Wednesday, November 22, 2023 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Thursday, December 5, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Description of Mark | The mark consists of a curved band in magenta displayed above the wording ,,INSTITUT ALLERGOSAN" in magenta. |
Indication of Colors claimed | The color(s) magenta is/are claimed as a feature of the mark. |
Goods and Services | Corporate management consultancy; providing office functions; advertising; public relations services; retail store services and online retail store services featuring cosmetics, skin care preparations, nutritional supplements, food supplements for dietetic use, food for medical or dietetic purposes, bacterial preparations for medical purposes, dietary supplements consisting primarily of vitamins and minerals for medical purposes and for dietetic purposes. |
NOT AVAILABLE | "INSTITUT" |
Translation of Words in Mark | The English translation of "INSTITUT" in the mark is "INSTITUTE". |
Goods and Services | Provision of research services in the fields of probiotic bacteria, microbiome research, healthcare preparations, plant extracts and minerals; scientific consultancy services and research in relation to probiotic bacteria, plant extracts and minerals; research and development in the field of healthcare preparations; microbiome research; scientific research; professional scientific advisory services on drawing up scientific studies; professional scientific advisory services on the subject of scientific reports and postings; technical writing, namely preparation of scientific reports and preparation of scientific contributions in the fields of probiotic bacteria, microbiome research, healthcare preparations, plant extracts and minerals; conducting scientific analyses in the fields of probiotic bacteria, microbiome research, healthcare preparations, plant extracts and minerals; provision of scientific information and provision of counselling services in the field of clinical research. |
Classification Information
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 2, 2024 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 2, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Institut Allergosan pharmazeutische Produkte |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | AT |
Trademark Events
Event Date | Event Description |
Thursday, May 2, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Monday, May 13, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, May 13, 2024 | APPLICATION FILING RECEIPT MAILED |
Tuesday, June 25, 2024 | ASSIGNED TO EXAMINER |
Thursday, June 27, 2024 | NON-FINAL ACTION WRITTEN |
Friday, June 28, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, July 25, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Thursday, July 25, 2024 | REFUSAL PROCESSED BY MPU |
Sunday, August 11, 2024 | REFUSAL PROCESSED BY IB |
Thursday, December 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, December 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, December 5, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |